Finally, to determine whether new MFGE8-blocking agents, such as the antibodies identified above, could be used for treatment of other tumors, we analyzed MFGE8 expression by immunohistochemistry in our collection of breast tumor biopsies generated from patients treated at Institut Curie (Table S2). The gene discussed is MFGE8; the disease is breast neoplasm.